Free Daily Podcast Summary
ATTD: Advanced Technologies and Treatments for Diabetes: Daily Summaries Delivered
by ATTD on UNLOK
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect, and previously Long-Acting Insulin Uncovered and CGM in Focus. Whether you're a specialist, researcher, or industry leader.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 1 weeks ago12 min
Managing Hypoglycemia with Weekly Insulin
Welcome back to ATTD Diabetes Talks! In Episode 5 of our series, The Power of Weekly Insulin, host Diana Isaacs is joined by Marissa Bowdler, PharmD, BCACP, TTS (Ambulatory Care Clinical Specialist in Endocrinology at Indiana University Health), to discuss critical strategies for managing and preventing hypoglycemia with weekly insulin therapy.In this episode, we cover:How hypoglycemia risk with weekly insulin compares to daily basal insulinKey patient and treatment risk factors for hypoglycemiaEssential preventative strategies when initiating weekly insulin therapyPatient education techniques for recognizing and managing hypoglycemiaRecommended clinical approaches for treatmentThe role of Continuous Glucose Monitoring (CGM) and digital tech in hypoglycemia prevention📌 Visit the ATTD Education Portal for exclusive content and resources: [ATTD Education Portal]🔔 Subscribe to the channel and share this episode with colleagues advancing diabetes care!This series is produced by Cue and supported by Eli Lilly & Company.#Diabetes #Endocrinology #Hypoglycemia #WeeklyInsulin #ATTD #DiabetesCare #Pharmacy #CGM #HealthcareProfessionals
- 3 weeks ago17 min
Starting and Titrating Weekly Insulin
In this episode of ATTD Diabetes Talks: The Power of Weekly Insulin, host Diana Isaacs joins Dr. Alice Cheng to discuss practical strategies for starting and titrating weekly insulin in routine clinical practice.Key Discussion Points:Initiating weekly insulin therapy in routine clinical practiceKey considerations when determining the starting doseHow titration differs from daily basal insulin regimensRecommended monitoring approaches during the initiation phaseCommon challenges in early treatment and real-world strategies to overcome themGuest: Dr. Alice Cheng (Professor at the University of Toronto; Endocrinologist at Trillium Health Partners and St. Michael’s Hospital)You can find more resources on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.This series is supported by Eli Lilly & Company.
- Oct 6, 202615 min
Choosing the Right Patient for Weekly Insulin
In this episode of ATTD Diabetes Talks, host Diana Isaacs is joined by Dr. Medha Munshi, Director of the Joslin Geriatric Diabetes Program and Professor of Medicine at Harvard Medical School. Together, they discuss the science behind weekly insulin, patient selection criteria, tailoring therapy to individual needs, and specific considerations for older or medically complex adults.Key Takeaways:Criteria & Patient Characteristics for Weekly InsulinManaging Resistance, Comorbidities & LifestyleBenefits for Older Adults & Complex PatientsIndividualizing Treatment & Best PracticesYou can find more resources on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.This series is supported by Eli Lilly & Company.
- Sep 22, 202621 min
The Science Behind Weekly Insulin
In this episode, we explore the science behind weekly insulin, including the pharmacology of weekly insulin, its mechanism of action, how it differs from daily insulin formulations, and why it provides consistent control over a longer period.Guest: Dr. Manasi Shah, Assistant Professor of Medicine at Eastern Virginia Medical School and Director of the Inpatient Diabetes Program at Sentara Norfolk General HospitalKey discussion points:What are the key pharmacokinetic properties that enable once-weekly insulin administration?How does the pharmacodynamic profile differ from that of daily basal insulin formulations?What mechanisms allow weekly insulin to provide sustained glucose control over several days?How does this prolonged action translate into clinical glycemic stability?What are the key pharmacological considerations clinicians should be aware of when interpreting data on weekly insulin?What remaining scientific questions need to be addressed before broader clinical adoption?You can find more resources on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.This series is supported by Eli Lilly & Company
- Sep 8, 202618 min
The Weekly Insulin Breakthrough
In this inaugural episode of ATTD Diabetes Talks: The Power of Weekly Insulin, we delve into the evolution and future of basal insulin therapy. Host Diana Isaacs sits down with Dr. Rodolfo Galindo to explore the pharmacological innovations behind weekly insulin formulations and discuss how this breakthrough is reshaping modern diabetes management.Guest: Dr. Rodolfo Galindo (Associate Professor of Medicine and Director of the Comprehensive Diabetes Center at the University of Miami Health System)Key Topics Covered:The Evolution of Basal Insulin: A look back at the progression from early long-acting formulations to current weekly treatment options.Pharmacological Innovation: Understanding the science that makes weekly insulin formulations possible.Clinical Advantages: Exploring the theoretical benefits of weekly versus daily basal insulin.Patient Impact: Examining how shifting to a weekly regimen affects treatment burden and overall patient experience.Future Outlook: How weekly insulin is poised to fit into the broader landscape of diabetes care.Resources:For more in-depth knowledge and exclusive content, visit the ATTD Education Portal.Subscribe to the podcast to stay updated on the latest in diabetes management.
- Aug 25, 202624 min
Unmet needs in paediatric diabetes – the potential role of inhaled insulin
Join host Dr. David Ahn and guest Dr. Michael Haller (Professor and Chief of Pediatric Endocrinology at the University of Florida and Chair of TrialNet) as they take a comprehensive review of the evidence base and remaining gaps for inhaled insulin use in pediatric and adolescent populationsIn this final episode, we dive into:Key Challenges in Pediatrics: Unmet needs in pediatric insulin therapy, including injection fatigue and tech-retention issues for active youth.The INHALE-1 Study: A deep dive into the randomized controlled trial data of 230 youth, highlighting efficacy, per-protocol non-inferiority, less weight gain, and superior treatment satisfaction among kids and parents.Safety Profile: Analyzing forced expiratory volume (FEV1) data showing an excellent safety signal with no differences in pulmonary function or severe hypoglycemic events.Practical Toolkit Use Cases: How the unique pharmacokinetic profile of inhaled insulin provides unmatched benefits for covering adrenaline-rush highs and avoiding hypoglycemia tail effects during sports and exercise.Dosing Guidelines: Overcoming the practical "paradigm shift" of converting injected units to inhaled units and managing dosing effectively.Future Horizons: Anticipating the "INHALE FIRST" study investigating early onboarding for newly diagnosed patients and introducing a new two-unit inhaled insulin cartridge.About ATTD Diabetes Talks:A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation.Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/Subscribe to the podcast for more updates on advancing diabetes care.#DiabetesManagement #PediatricEndocrinology #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Type1DiabetesChapters:00:00 Intro and Unique Challenges in Pediatric Diabetes Management02:38 The INHALE-1 Study: Efficacy, Satisfaction, and Weight Findings06:27 Safety Signals, Pulmonary Function, and Adherence Challenges10:18 Practical Toolkit Use Cases: Managing Sports and Exercise12:48 Dosing Conversions and Practical Patient Selection Guidelines15:02 Off-Label Integration with Automated Insulin Delivery (AID) Systems20:14 Caregiver & School Nurse Roles and Managing Safety Concerns22:00 Research Gaps, The INHALE FIRST Trial, and Wrap Up
- Aug 18, 202621 min
Use of inhaled insulin with automated insulin delivery (AID) systems
Join host Dr. David Ahn and guest Dr. Roy Beck (Founder and Medical Director of the Jaeb Center for Health Research) as they explore the integration of inhaled insulin with automated insulin delivery (AID) systems.In this episode, we dive into:The potential of combining inhaled insulin with current AID technologies.Theoretical advantages, including postprandial management.Current evidence, clinical considerations, and existing evidence gaps.Practical insights for clinicians on patient education and system integration.About ATTD Diabetes Talks:A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation.Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/Subscribe to the podcast for more updates on advancing diabetes care.#DiabetesManagement #AIDSystems #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #EndocrinologyChapters:00:00 Intro03:03 How Inhaled Insulin Works07:30 Real World Dosing Workflow10:24 Exercise and Safety Upside15:45 Clinician Education Tips17:38 Research Gaps and Trials Needed19:32 Future Potential and Wrap Up
- Aug 11, 202616 min
Overcoming therapeutic inertia with inhaled insulin
In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation.Key discussion points:Defining therapeutic inertia in the context of insulin initiation.Common clinician and patient-related barriers that contribute to treatment delays.Practical strategies for introducing inhaled insulin to hesitant patients.System-level considerations, including workflow and reimbursement challenges.Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together.#DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcastChapters:00:00 Why Inhaled Insulin Matters00:34 Show Intro and Guest01:22 Defining Therapeutic Inertia02:19 Clinician Barriers to Insulin03:49 Patient Fears and Hesitation05:28 How Inhaled Insulin Helps07:00 Best Fit Patient Scenarios08:22 Talking to Hesitant Patients10:39 Workflow and Coverage Hurdles13:35 PFT Testing and Side Effects14:47 Future Role and Wrap Up
Get ATTD: Advanced Technologies and Treatments for Diabetes summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Diabetes Nerd
Discusses diabetes research, technology, management strategies, and personal stories through candid conversations.
ICU Ed and Todd-Cast
Eddie and Todd
The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.
In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.
Treated with Dr. Sara Szal
Dr. Sara Szal explores holistic health solutions through conversations with experts and patients seeking mind, body, and soul healing.
DGTL Voices with Ed Marx
Conversations with leaders and innovators driving digital transformation in healthcare.
TED Tech
Experts examine how technology reshapes society, science, design, and business through TED Talks hosted by Sherrell Dorsey.
Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.
The Hunter Williams Podcast
Explores cutting-edge science in peptides, hormone optimization, and biohacking with experts pushing the limits of human performance.
A Shot in the Arm Podcast
Ben Plumley
The Holistic GLP-1 Podcast with Elizabeth McGann
Explores holistic approaches to GLP-1 for metabolic health, weight, and well-being through expert insights and natural strategies.
Extend Podcast with Darshan Shah, MD
Explores science-backed strategies and expert insights to extend healthspan and optimize longevity through actionable health protocols.
About ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect, and previously Long-Acting Insulin Uncovered and CGM in Focus. Whether you're a specialist, researcher, or industry leader.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from ATTD: Advanced Technologies and Treatments for Diabetes in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's ATTD: Advanced Technologies and Treatments for Diabetes daily summary?
It's a free AI-powered email that summarizes new episodes of ATTD: Advanced Technologies and Treatments for Diabetes as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the ATTD: Advanced Technologies and Treatments for Diabetes podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official ATTD: Advanced Technologies and Treatments for Diabetes product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by ATTD on UNLOK.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does ATTD: Advanced Technologies and Treatments for Diabetes release new episodes?
ATTD: Advanced Technologies and Treatments for Diabetes publishes biweekly. Our AI generates a summary within hours of each new episode.
What topics does ATTD: Advanced Technologies and Treatments for Diabetes cover?
ATTD: Advanced Technologies and Treatments for Diabetes covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting ATTD: Advanced Technologies and Treatments for Diabetes summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.